BioSight
Companies
Benitec Biopharma Inc. logo

BNTC

NASDAQHAYWARD, CA
Benitec Biopharma Inc.

Benitec Biopharma is a gene therapy company developing ddRNAi (DNA-directed RNA interference) technology for therapeutic applications. While the excerpt provided does not specify particular lead programs, therapeutic areas, or current development stages, the company's tagline "Silencing Genes for Life" indicates focus on gene silencing approaches, with mention of potential future clinical trials and regulatory filings.

Price history not yet available for BNTC.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar